Nova One Advisor

Global (High-Performance Liquid Chromatography) HPLC Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 2273 Format: PDF / PPT / Excel

Content


Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 1 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 13 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 13 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 17 in /home/multiwpmr/public_html/report-details.php on line 448

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: expecting ';' in Entity, line: 17 in /home/multiwpmr/public_html/report-details.php on line 448
The global market for HPLC is estimated to have a CAGR of around 5% during the forecast period. HPLC instrument has the ability to separate and identify the biological component that is present in any sample. HPLC has been used in a wide range of industrial and scientific applications includes biopharmaceuticals, forensics, and chemicals. Various universities are developing an HPLC platform for metabolomics applications. For instance, Osaka and Kyushu University in Japan are making efforts in order to develop a metabolomic platform based on micro-2D-HPLC that will be able to detect whole sets of chiral amino acids from human samples with precision. The factors that are contributing to the growth of the market include growing pharmaceutical R&D, growing demand for HPLC test in clinical approvals and others.



Segmental Outlook



The global HPLC market is segregated on the basis of product type and application. On the basis of product type, the global HPLC market is classified into consumables, instruments, accessories. The consumables segment is projected to hold a significant growth in the global HPLC market owing to the growing application of consumables in clinical research applications. The consumables include columns, filters, tubes and vials that are significantly used with HPLC systems in various applications. On the basis of the application, the market is further segmented into diagnostics, clinical research, forensics, and others.



Global HPLC market to be driven by Clinical Research



The clinical research application segment projected to have considerable market growth in the global HPLC market owing to the major application of the HPLC instruments in research application as these instruments play an essential role in research activity. The advances in the research areas have enhanced the understanding of improved therapeutic strategies and disease pathology for several diseases with unmet challenges. Furthermore, the advances would positively impact the development of potential drugs and innovative therapies that can help people with chronic and life-threatening diseases. Moreover, growing clinical research across the globe further contributes to the market. For instance, in December 2018 the Municipal Institute for Medical Research started the clinical study by the collaboration with the University of Barcelona for studying novel predictive biomarkers.



Regional Outlook



Geographically, the global high-performance liquid chromatography market is further classified into North America, Europe, Asia-Pacific and the Rest of the World. Asia-Pacific is anticipated to have lucrative market growth in the global HPLC market during the forecast period. The HPLC market in Asia-Pacific is mainly driven by the contribution of major countries such as China, India, Japan and the rest of Asia-Pacific countries. The factors that are contributing to the growth of the market include the growing pharmaceutical and biotechnology industry in these economies and growing proteomics study and clinical research. The government of Japan is making continuous efforts for the establishment of R&D centers by foreign-affiliated companies. The government is focusing to make Japan a global hub of trade and investments and will focus on R&D centers as part of the efforts for this purpose.



North America to hold a considerable share in the global C-RAN market



Geographically, North America is projected to have a significant share in the global HPLC market. The US and Canada are significantly contributing to the market growth due to various factors such as well-developed healthcare infrastructure, increasing healthcare R&D investments, high healthcare expenditure and increasing health consciousness, and so on. Accordingly, the healthcare expenditure rate of the US is more than that of Canada, as the US government invests more in R&D. Furthermore, socio-economic factors such as healthcare, income, population base creates more business opportunity in the US as compared to Canada. Moreover, the market growth is attributed to the rising prevalence of cancer, CVDs and chronic diseases coupled with growing clinical research on these diseases.



Market Players Outlook



The key players in the HPLC market contributing significantly by providing different applications of products and increasing their geographical presence across the globe. The key players of the market include Agilent Technologies, Inc., Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific Inc., Waters Corp., Bio-Rad Laboratories, Inc., Gilson Inc., Shimadzu Corp., Tosoh Corp., and others. These market players adopt various strategies such as product launch, partnerships, collaborations, mergers, and acquisitions to sustain a strong position in the market.



  • Insight Code: 2273
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: June 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034